HEPACAM: Involved in regulating cell motility and cell-matrix interactions. May inhibit cell growth through suppression of cell proliferation. Defects in HEPACAM are the cause of leukoencephalopathy megalencephalic with subcortical cysts type 2A (MLC2A). MLC2A is a neurodegenerative disorder characterized by infantile-onset macrocephaly and later onset of motor deterioration, with ataxia and spasticity, seizures, and cognitive decline of variable severity. The brain appears swollen on magnetic resonance imaging with white-matter abnormalities and subcortical cysts, in all stages of the disease. Defects in HEPACAM are the cause of leukoencephalopathy megalencephalic with subcortical cysts type 2B (MLC2B). MLC2B is a neurodegenerative disorder characterized by infantile-onset of macrocephaly and mildly delayed motor development associated with white-matter abnormalities on brain magnetic resonance imaging. The phenotype is milder that MLC2A, with better preserved cerebellar white matter and no subcortical cysts outside the temporal region. On follow-up, patients show normal or almost normal motor function. Some patients have normal intelligence, whereas others have a significant cognitive deficiency. 2 isoforms of the human protein are produced by alternative splicing.
Protein type: Membrane protein, integral
Chromosomal Location of Human Ortholog: 11q24.2
Cellular Component: axon; cytoplasm; integral to membrane; intercellular junction
Biological Process: regulation of growth; cell cycle arrest; cell adhesion
Disease: Megalencephalic Leukoencephalopathy With Subcortical Cysts 2b, Remitting, With Or Without Mental Retardation; Megalencephalic Leukoencephalopathy With Subcortical Cysts 2a; Megalencephalic Leukoencephalopathy With Subcortical Cysts 1
Show more